IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
HPC Biosciences IPO listing price is ₹ 39.10, issue price is [●], and currently trading at ₹ 26.20 as on [●]. HPC Biosciences IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
HPC Biosciences IPO is a Fixed Price listing on BSE SME exchange. The company is based in New Delhi and caters to Agro sector. Guiness Corporate Advisors is the merchant banker of HPC Biosciences IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on [●].
HPC Biosciences IPO offer price is ₹ 35.00 and got listed at ₹ 39.10. Read HPC Biosciences IPO details mentioned above.The IPO of HPC Biosciences Limited was listed on 19th March 2013. As of today, HPC Biosciences IPO is trading at ₹ 26.20, compared to the previous day’s close of [●]. Read the report above for detailed IPO performance.
The issue price of HPC Biosciences IPO was [●] per equity share.
HPC Biosciences IPO was listed at ₹39.10 on the stock exchange on 19th March 2013. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of [●], the current market price of HPC Biosciences IPO is ₹ 26.20.
The 52-week high for HPC Biosciences IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The HPC Biosciences IPO listed at ₹ 39.10 against the issue price of [●] per equity share, showing a listing day gain/loss of 35.6 (1,017.14%) , calculated by comparing the listing price to the issue price on the first day of trading.
The HPC Biosciences IPO stock moved from its listing price of ₹ 39.10 to the current price of ₹26.20 per equity share, reflecting a change of 570.08% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on HPC Biosciences IPO issue date of [●] and CMP of ₹26.20, the estimated CAGR is approximately 17.93%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 1
Issue
Price :
[●]
Listing Price :
₹ 39.10
Previous Day Closing
[●]
HPC Biosciences IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on HPC Biosciences Financial Review Page
Merchant Banker(s) of HPC Biosciences IPO: Guiness Corporate Advisors Private Limited
HPC Biosciences IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
HPC Biosciences IPO listed at a listing price of 39.10 against the offer price of 35.00.
The current market price of HPC Biosciences is 26.20.
Why Us?
